Terence L Ahern1, Andrew A Herring1,2, Steve Miller1, Bradley W Frazee1,2. 1. Departments of Emergency Medicine, Alameda Health System, Highland Hospital, Oakland. 2. Emergency Medicine, University of California, San Francisco, California, USA.
Abstract
OBJECTIVE: Use of low-dose ketamine infusions in the emergency department (ED) has not previously been described, despite routine use in perioperative and other settings. Our hypothesis was that a low-dose ketamine bolus followed by continuous infusion would 1) provide clinically significant and sustained pain relief; 2) be well tolerated; and 3) be feasible in the ED. METHODS: We prospectively administered 15 mg intravenous ketamine followed immediately by continuous ketamine infusion at 20 mg/h for 1 hour. Optional morphine (4 mg) was offered at 20, 40, and 60 minutes. Pain intensity, vitals signs, level of sedation, and adverse reactions were assessed for 120 minutes. RESULTS: A total of 38 patients were included with a median initial numerical rating scale (NRS) pain score of 9. At 10 minutes, the median reduction in pain score was 4, with 7 patients reporting a score of 0. At 60 and 120 minutes, 25 and 26 patients, respectively, reported clinically significant pain reduction (decrease NRS score > 3). Heart rate, blood pressure, respiratory rate, and oxygen saturation remained stable. Mild or moderate side effects including dizziness, fatigue, and headache were common. Patient satisfaction was high; 85% reported they would have this medication again for similar pain. CONCLUSION: A low-dose ketamine infusion protocol provided significant pain relief with mostly mild side effects and no severe adverse events. Wiley Periodicals, Inc.
OBJECTIVE: Use of low-dose ketamine infusions in the emergency department (ED) has not previously been described, despite routine use in perioperative and other settings. Our hypothesis was that a low-dose ketamine bolus followed by continuous infusion would 1) provide clinically significant and sustained pain relief; 2) be well tolerated; and 3) be feasible in the ED. METHODS: We prospectively administered 15 mg intravenous ketamine followed immediately by continuous ketamine infusion at 20 mg/h for 1 hour. Optional morphine (4 mg) was offered at 20, 40, and 60 minutes. Pain intensity, vitals signs, level of sedation, and adverse reactions were assessed for 120 minutes. RESULTS: A total of 38 patients were included with a median initial numerical rating scale (NRS) pain score of 9. At 10 minutes, the median reduction in pain score was 4, with 7 patients reporting a score of 0. At 60 and 120 minutes, 25 and 26 patients, respectively, reported clinically significant pain reduction (decrease NRS score > 3). Heart rate, blood pressure, respiratory rate, and oxygen saturation remained stable. Mild or moderate side effects including dizziness, fatigue, and headache were common. Patient satisfaction was high; 85% reported they would have this medication again for similar pain. CONCLUSION: A low-dose ketamine infusion protocol provided significant pain relief with mostly mild side effects and no severe adverse events. Wiley Periodicals, Inc.
Authors: Leorey N Saligan; David A Luckenbaugh; Elizabeth E Slonena; Rodrigo Machado-Vieira; Carlos A Zarate Journal: J Psychiatr Res Date: 2015-06-24 Impact factor: 4.791
Authors: Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten Journal: Reg Anesth Pain Med Date: 2018-07 Impact factor: 6.288
Authors: Ashley R Etchison; Lia Bos; Meredith Ray; Kelly B McAllister; Moiz Mohammed; Barrett Park; Allen Vu Phan; Corey Heitz Journal: West J Emerg Med Date: 2018-09-10
Authors: Mohammed S Alshahrani; Laila Perlas Asonto; Mohamed M El Tahan; Amal H Al Sulaibikh; Sukayna Z Al Faraj; Abdullah A Al Mulhim; Murad F Al Abbad; Samar A Al Nahhash; Moath N Aldarweesh; Alaa M Mahmoud; Nisreen Almaghraby; Mohammed A Al Jumaan; Thamir O Al Junaid; Faisal M Al Hawaj; Samar AlKenany; Omaima F ElSayed; Haitham M Abdelwahab; Mohamed M Moussa; Bader K Alossaimi; Shaikah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman; Saad D Al Shahrani; Donia Alfaraj; Waleed Alhazzani Journal: Trials Date: 2019-05-27 Impact factor: 2.279
Authors: Sergey Motov; Jefferson Drapkin; Antonios Likourezos; Tyler Beals; Ralph Monfort; Christian Fromm; John Marshall Journal: West J Emerg Med Date: 2018-03-08
Authors: Viviane S Hambrecht-Wiedbusch; Katherine A LaTendresse; Michael S Avidan; Amanda G Nelson; Margaret Phyle; Romi E Ajluni; George A Mashour Journal: Front Behav Neurosci Date: 2019-04-17 Impact factor: 3.558